10 Best Cheapest Stocks To Buy Right Now

Communication network solution provider ADTRAN Inc. (ADTN) reported strong second-quarter 2013 financial results, owing to strong contributions from its Internetworking and Broadband Access product divisions. The results were positively impacted by an improved spending atmosphere and increased strategic investment by its carrier customers. ADTRAN currently has a Zacks Rank #1 (Strong Buy).

In the second quarter of 2013, GAAP net income was $9.9 million or 17 cents per share compared with $21.1 million or 33 cents per share in the year-ago quarter. However, quarterly adjusted earnings per share were 18 cents, well above the Zacks Consensus Estimate of 15 cents per share. The company reported quarterly total revenue of $162.2 million, down 11.8% year over year but outpaced the Zacks Consensus Estimate of $153 million.

Quarterly gross margin was 49.2% compared with 51.7% in the prior-year quarter. Operating income registered a steep drop of 47.6% year over year t o $14.1 million. Quarterly operating margin was 8.7% compared with 14.6% in the prior-year quarter. The company’s board of directors declared a cash dividend of 9 cents per share for the quarter. The dividend will be paid on Aug 8 to shareholders of record as of Jul 25.

10 Best Cheapest Stocks To Buy Right Now: Alliance Data Systems Corporation (ADS)

Alliance Data Systems Corporation, together with its subsidiaries, provides data-driven and transaction-based marketing, and customer loyalty solutions primarily in the United States and Canada. The company operates in three segments: LoyaltyOne, Epsilon, and Private Label Services and Credit. The LoyaltyOne segment includes AIR MILES Reward Program that enables consumers to earn AIR MILES reward miles as they shop within a range of retailers and other sponsors participating in the AIR MILES Reward Program; and offers loyalty services, including loyalty consulting, customer analytics, and creative services. The Epsilon segment provides integrated direct marketing solutions, which combine database marketing technology and analytics with a range of direct marketing services comprising email marketing campaigns. This segment’s products and services consist of marketing database services, analytical services, strategic consulting and creative services, proprietary data service s, and digital communications. The Private Label Services and Credit segment encompasses credit card processing, billing and payment processing, customer care and collections services for private label retailers, as well as private label retail credit card receivables financing, including securitization of the credit card receivables that it underwrites from its private label retail credit card programs. The company serves financial services, specialty retail, grocery and drugstore chains, petroleum retail, technology, hospitality and travel, media, and pharmaceuticals end markets. Alliance Data Systems Corporation was founded in 1996 and is headquartered in Plano, Texas.

Advisors’ Opinion:

  • [By Sue Chang and Ben Eisen]

    Alliance Data Systems Inc. (ADS)  shares gained 9.3%. The operator of loyalty programs and private-label credit cards reported core earnings of $2.39 in the fourth quarter versus analysts’ estimate of $2.33 a share.

  • [By Tom Taulli]

    A key to Facebook’s monetization success has been the company’s aggressive investments in ad technologies. For example, by leveraging third-party data sources — such as from Datalogix, Acxiom (ACXM) and Alliance Data Systems (ADS) — it has been able to provide analytics on the performance of ad campaigns. On the Q4 earnings call, Facebook COO Sheryl Sandberg said the average return on News Feed ads was an incredible 8x.

  • [By Dan Caplinger]

    Facebook certainly took the spotlight in the decision from S&P Dow Jones Indices to include the social media giant in the S&P 500. But lost in the Facebook news was the fact that Alliance Data Systems (NYSE: ADS  ) and Mohawk Industries (NYSE: MHK  ) also gained admission to the prestigious index, while Abercrombie & Fitch (NYSE: ANF  ) , JDS Uniphase (NASDAQ: JDSU  ) , and Teradyne (NYSE: TER  ) made their exit. Let’s take a closer look at the other winners and losers in the Facebook index shuffle.

  • [By James O’Toole]

    S&P also announced Wednesday that clothing retailer Abercrombie & Fitch (ANF) and communication technology firm JDS Uniphase Corp. (JDSU) will be leaving the index, to be replaced by Alliance Data Systems (ADS) and floor-covering producer Mohawk Industries (MHK, Fortune 500).

10 Best Cheapest Stocks To Buy Right Now: Boyd Gaming Corporation(BYD)

Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company in the United States. As of December 31, 2011, the company owned and operated 1,042,787 square feet of casino space, containing approximately 25,973 slot machines, 655 table games, and 11,418 hotel rooms. It also owned and operated 16 gaming entertainment properties located in Nevada, Illinois, Louisiana, Mississippi, Indiana, and New Jersey. In addition, the company owns and operates a pari-mutuel jai-alai facility located in Dania Beach, Florida, as well as a travel agency in Hawaii. Further, it holds a 50% controlling interest in the limited liability company that operates Borgata Hotel Casino and Spa in Atlantic City, New Jersey. Boyd Gaming Corporation was founded in 1988 and is headquartered in Las Vegas, Nevada.

Advisors’ Opinion:

  • [By John Kell and Lauren Pollock var popups = dojo.query(“.socialByline .popC”); ]

    Among the companies with shares expected to actively trade in Tuesday’s session are American Eagle Outfitters Inc.(AEO), Boyd Gaming Corp.(BYD) and Dick’s Sporting Goods Inc.(DKS)

  • [By Wallace Witkowski]

    Shares of Boyd Gaming Corp. (BYD)  rose 8% to $12.75 on moderate volume after hedge fund Elliot Associates L.P. disclosed in a regulatory filing it had acquired a 4.99% stake in the casino operator.

10 Best Cheapest Stocks To Buy Right Now: Pernix Therapeutics Holdings Inc (PTX)

Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company’s branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.

The Company’s customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.

ALDEX Line

ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company’s ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongest ant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.

BROVEX Line

The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.

CEDAX Line

CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.

NATROBA Line

NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.

PEDIATEX Line

As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respirat ory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.

REZYST Line

REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.

Product Candidates in Development

Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.

Advisors’ Opinion:

  • [By Michael Douglass and David Williamson]

    Shares of Pernix Therapeutics  (NASDAQ: PTX  ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to GlaxoSmithKline’s (NYSE: GSK  ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix — the company had $85 million in revenue last year, while Treximet on its own brought in $79 million — and Pernix clearly sees some additional upside potential for the drug, whether it’s through a potential indication expansion (to pediatric patients) or through synergies with Pernix’s current salesforce.

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.

10 Best Cheapest Stocks To Buy Right Now: Hawkins Inc. (HWKN)

Hawkins, Inc. distributes bulk chemicals, as well as blends, manufactures, and distributes specialty chemicals. The company operates through two segments, Industrial and Water Treatment. The Industrial segment provides industrial chemicals, products, and services primarily to the agriculture, energy, electronics, food, chemical processing, pulp and paper, pharmaceutical, medical device, and plating industries. This segment primarily offers acids, alkalis, and industrial and food-grade salts; and receives, stores, and distributes various chemicals, including liquid caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. In addition, it manufactures sodium hypochlorite, agricultural products, and certain food-grade products comprising Cheese-Phos liquid phosphate, lactates, and other blended products; repackages water treatment and bulk industrial chemicals; and performs custom blending of certain chemicals, and contract and pr ivate label packaging for household chemicals. This segment primarily conducts its operations through distribution centers and terminal operations. The Water Treatment segment provides chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Hawkins, Inc. was founded in 1938 and is based in Minneapolis, Minnesota.

Advisors’ Opinion:

  • [By Seth Jayson]

    Hawkins (Nasdaq: HWKN  ) reported earnings on May 29. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q4), Hawkins met expectations on revenues and beat expectations on earnings per share.

10 Best Cheapest Stocks To Buy Right Now: Rite Aid Corp (RAD)

Rite Aid Corporation, incorporated in 1968, is a retail drugstore chain in the United States. As of March 3, 2012, the Company operated drugstores in 31 states across the country and in the District of Columbia. As of March 3, 2012, it operated 4,667 stores. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2012 (fiscal 2012), prescription drug sales accounted for 68.1% of its total sales. The Company carries a range of front end products, which accounted for 31.9% of its total sales in fiscal 2012. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchandise and other everyday and convenience products, as well as photo processing. It offers a variety of products under its private brands, which contributed approximately 17% of it s front end sales in the categories where private brand products were offered in fiscal 2012. As of March 3, 2012, the Company had opened over 2,100 GNC stores-within-Rite Aid-stores. During fiscal 2012, the Company sold two owned operating stores to independent third parties.

During fiscal 2012, its stores filled approximately 295 million prescriptions and served an average of 2.1 million customers per day. The overall average size of each store in its chain is approximately 12,600 square feet. As of March 3, 2012, 60% of its stores were freestanding; 51% of its stores included a drive-thru pharmacy; 24% included one-hour photo shops, and 46% included a GNC store-within-Rite Aid-store. The Company’s customers may also order prescription refills over the Internet through www.riteaid.com, or over the phone through its telephonic automated refill systems for pick up at a Rite Aid store. It has a strategic alliance with GNC, a retailer of vitamin and mineral supp lements.

Advisors’ Opinion:

  • [By WWW.DAILYFINANCE.COM]

    AlamyWebsites can help direct you to beauty-related freebies. Inner beauty matters most in my book, but trying to look your best outwardly can be important, too. Striving for beauty on the outside by using beauty products can help boost your confidence and show others that you take good care of yourself. On average, Americans spend more than $400 a year on personal care products. Although cosmetics and beauty products can add up to a pretty penny, beauty doesn’t need to come with a hefty price tag. Here are some tips to manage beauty on a budget. 1. Free Samples Marketers love giving out free samples so consumers have the chance to try new products and fall in love with their products. The hope is that if you try a little, you’ll like it enough to buy the full-size product at its full retail price. For frugal shoppers, free samples can be a tool that allows us the chance to stretch our dollars. By taking advantage of a variety of free beauty samples from many manufacturers, over time we can end up with enough free sample products to replace a few full-size ones. One woman who has perfected the search for freebies is Heather Hernandez, founder of Freebies4Mom.com. She started her site, which curates the best free samples available online, back in 2007. By signing up for her free e-mail newsletter you can be notified when new free samples are available and where to get them. Besides visiting Freebies4Mom.com, Heather shares two of her favorite sources for online freebies: SampleSource and PinchMe. SampleSource.com is a relatively new site that allows users to get free brand name samples. She recently received a free shampoo and new toothbrush from their site, which is free to join. PinchMe.com allows consumers to try free products in exchange for providing feedback on a short survey. On her last visit to the site, she got to select a free nail polish in the color of her choice PinchMe has become very popular, so she recommends that you “pay attention to

  • [By Muhammad Bazil]

    Companies like J.C. Penney (JCP) on their way to recovery through turnaround initiatives often pose two challenges to investors. It’s either the turnaround leads to a costly adventure and loss of investors’ hard earned money or it brings enormous profit to investors who had the courage to make the right bets. J.C. Penney is a retail company on the verge of booking increases on its top line if consumer spending continues to improve into holiday and back-to-school seasons ahead. With the turnaround stepsbeing taking so far by JCP, the retail company now falls into the same category with Best Buy (BBY) and Rite Aid (RAD) but while Best Buy and Rite Aid retails technology products and drugs respectively, JCP retails family apparel, footwear accessories, home furnishings, and a range of beauty products through its departmental stores across the U.S.

10 Best Cheapest Stocks To Buy Right Now: Genomma Lab Internacional SAB de CV (LABB.MX)

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. Advisors’ Opinion:

  • [By Ben Levisohn]

    He then took a deep dive into Genomma Lab (LABB.MX), a Mexican producer of over-the counter pharmaceuticals, generic drugs, and personal care products. Now, I’m sitting with a Chromebook in a large auditorium, so I hope I’ve captured the essence of his argument.

10 Best Cheapest Stocks To Buy Right Now: Compucon Computer Applications SA (COMP)

Compucon Computer Applications SA is a Greek company engaged mainly in the information technology sector. The Company’s activities include the manufacture and trade of electronics and software for the embroidery, telematics, laser, Web solutions and medical fields. In the embroidery field it offers album presentation or embroidery designs, lettering with a variety of fonts, frames and specialized features, and realistic three-dimensional views of embroidery designs. The Company also produces laser cutting and engraving devices for the embroidery sector. The range of telematics applications includes automotive positioning systems, fleet management and navigation systems. Its Web solutions offering includes the SiteCosmos, which is an integrated tool for on-line content management and Website design for small and medium enterprises, while the medical applications target the management of patient-oriented information, diet schedules, word processing, prescriptions and other serv ices. Advisors’ Opinion:

  • [By Carla Mozée]

    U.S. stocks closed Monday’s session higher, led by small-cap and tech companies. Analysts noted that Wall Street’s trading volumes were the third-lowest this year, saying an absence of ‘bad news’ helped support gains. Among key benchmarks, the Nasdaq Composite (COMP)  rose 0.9%, and the Russell 2000 (RUT) index of small stocks ended 1% higher.

  • [By Wallace Witkowski]

    Last week, the Nasdaq Composite Index (COMP) rose 0.5%. It’s moved between weekly gains and losses for six straight weeks.

  • [By Anora Mahmudova]

    The Nasdaq Composite (COMP)  shed 16.18 points, or 0.4%, to 4,051.50, losing 2.1% over the past three sessions. Biotech stocks sold off, with the Nasdaq Biotechnology index (NBI)  down 1.9%.

  • [By Benjamin Pimentel]

    The Nasdaq Composite Index (COMP)  fell 0.4% to close at 4,052. The Morgan Stanley High Tech 35 Index (MSH)  and the Philadelphia Semiconductor Index (SOX)  each gained a fraction.

10 Best Cheapest Stocks To Buy Right Now: Nuverra Environmental Solutions Inc (NES)

Nuverra Environmental Solutions, Inc., formerly Heckmann Corporation, incorporated on May 29, 2007, provides environmental solutions to protect, enhance and advance environmental sustainability. Nuverra provides full-cycle environmental solutions to a national customer base consisting of two distinct end markets: Shale Solutions and Industrial Solutions.

The Company is focused on the removal, treatment, recycling, transportation and disposal of restricted solids, fluids and hydrocarbons for E&P customers. It also provides a one-stop-shop for energy recovery, re-refining and recycling of used motor oil and oily wastewater; plus a closed loop spent antifreeze program for retail, automotive and manufacturing customers. Nuverra specializes in providing environmentally compliant and sustainable solutions to a national footprint of customers.

Shale Solutions

Shale Solutions provides environmental solutions for unconventional oil and gas ex ploration and production, including the delivery, collection, treatment, recycle, and disposal of restricted environmental products used in the development of unconventional oil and natural gas fields. The Company operates in select shale areas in the United States, including the Marcellus/Utica, Eagle Ford, Bakken, Haynesville, Barnett, Permian, Mississippian Lime and Tuscaloosa Marine Shale areas. It serves customers seeking fresh water acquisition, temporary water transmission and storage, transportation, treatment or disposal of fresh water and complex water flows, such as flowback and produced brine water, in connection with shale oil and gas hydraulic fracturing drilling or hydrofracturing operations. The Company also transports fresh water for production and provides services for site preparation, water pit excavations and remediation.

Industrial Solutions

Industrial Solutions provides environmental and waste recycling solutions to its custom ers through collection and recycling services for waste prod! ucts, including UMO, which the Company processes and sells as RFO, oily water, spent antifreeze, used oil filters and parts washers, and provision of complementary environmental services for a diverse commercial and industrial customer base. Industrial Solutions operates a scalable network infrastructure of 34 processing facilities, approximately 385 tanker trucks, vacuum trucks and trailers and over 200 railcars. With a geographic presence in 19 states in the Western United States stretching from Washington to Texas, Industrial Solutions provides its services to a diverse range of more than 20,000 commercial and industrial customer locations.

Advisors’ Opinion:

  • [By Dan Caplinger]

    Stocks finished the week on the plus side, as the Dow hit a new high, and the broader market held its own against more bearish investors who are arguing more forcefully that the long bull market has to come to an end at some point. Several stocks helped to build some excitement for market participants, and Clean Energy Fuels (NASDAQ: CLNE  ) , Universal Display (NASDAQ: OLED  ) , and Nuverra Environmental Solutions (NYSE: NES  ) were among the best-performing stocks in the market Friday.

  • [By Wallace Witkowski]

    Shares of Nuverra Environmental Solutions Inc. (NES)  fell 5.6% to $16.99 on moderate volume after the company announced it was selling its industrial solutions unit, Thermo Fluids Inc., to VeroLube for $175 million.

  • [By Monica Gerson]

    Nuverra Environmental Solutions (NYSE: NES) is expected to post a Q4 loss at $0.47 per share on revenue of $152.06 million.

    PowerSecure International (NYSE: POWR) is estimated to post its Q4 earnings at $0.09 per share on revenue of $69.18 million.

  • [By Traders Reserve]

    Nuverra Environmental Services (NES) revenue more than doubled to $351 million in 2012 and will come close to doubling again in 2013 once earnings are reported. Nuverra trucks water and provides water-related services to clean up after a shale field is fracked. That said, Nuverra is over-leveraged and while this was acceptable as it was growing and growing, it is beginning to feel competitive pressure from pipelines and other water trucking companies.

10 Best Cheapest Stocks To Buy Right Now: Wasgau Produktions & Handels AG (MSH)

Wasgau Produktions & Handels AG is a Germany-based retailer and producer of food articles. The Company divides its business activities into the two main segments Wholesale and Retail. The Wholesale’s businesses include seven Cash and Carry markets for restaurateurs and wholesale customers, as well as commercial businesses of the holding company WASGAU Produktions & Handels AG, which are supported by its subsidiary WASGAU Dienstleistungs & Logistik GmbH, active within warehouse management and transportation. The Operations within the Retail segment are mainly carried out through Company’s subsidiaries WASGAU Metzgerei GmbH and WASGAU Baeckerei & Konditorei GmbH, which produce and supply its stores with a variety of meats and bakery products, respectively. As of December 31, 2011, the Company operated through 24 affiliated companies and subsidiaries located in Germany. Advisors’ Opinion:

  • [By Benjamin Pimentel]

    The Nasdaq Composite Index (COMP)  fell 0.4% to close at 4,052. The Morgan Stanley High Tech 35 Index (MSH)  and the Philadelphia Semiconductor Index (SOX)  each gained a fraction.

  • [By Benjamin Pimentel]

    But the Nasdaq Composite Index (COMP)  edged higher by 0.2% to close at 4,276, even as the Morgan Stanley High Tech 35 Index (MSH)  and the Philadelphia Semiconductor Index (SOX) were each down a fraction.

  • [By Benjamin Pimentel]

    The Nasdaq Composite Index (COMP)  gave up 6 points to close at 4,352. But the benchmark ended the week up 1%. The Morgan Stanley High Tech 35 Index (MSH)  also was down a fraction on Friday, while the Philadelphia Semiconductor Index (SOX) was up 0.7%.

  • [By Benjamin Pimentel]

    The Nasdaq Composite Index (COMP)  gained 6 points, or 0.1%, to close at 4,358. The Morgan Stanley High Tech 35 Index (MSH)  and the Philadelphia Semiconductor Index (SOX)  were each up a fraction.

10 Best Cheapest Stocks To Buy Right Now: ResMed Inc (RMD)

ResMed Inc., (ResMed), incorporated on March 31, 1994, is a holding company for the ResMed Group. The Company, through its subsidiaries, is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB) includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. The Company has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Its manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. In December 2013, ResMed Inc acquired Unimedis SRO, a surgical appliance and manufacturing company.

Air Flow Generators

The Company produces continuous positive airway pressure (CPAP), variable positive airway pressure (VPAP) and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. Its VPAP units deliver bilevel therapy. There are two preset pressures: a higher pressure as the patient breathes in, and a lower pressure as the patient breathes out. AutoSet systems are based on a technology to monitor breathing and can also be used in the diagnosis, treatment and management of OSA. The Company’s Stellar 100 and 150 ventilation devices, provide both invasive and non invasive ventilation applications for adult and pediatric patients.

ResMed Inc.’s CPAP products include S8 Escape, S9 Elite and S9 Escape. Its VPAP products include VPAP III STA with QuickNav, VPAP S / VPAP IV, VPAP IV ST, S8 Auto 25, VPAP Tx Lab System, S9 VPAP S, S9 VPAP ST! , S9 VPAP Auto, S9 VPAP Adapt, S9 AutoSet CS, S9 Auto 25 and S9 VPAP COPD. The Company’s automatic positive airway pressure products include S9 AutoSet and S9 Escape Auto. Its ventilation products include Elisee 150, VS III and Stellar 100 and 150.

Masks, Accessories, Motors and Diagnostic Products

Masks, accessories, motors and diagnostic products together accounted for approximately 46% of its net revenues in fiscal 2012. Its Mask products include Activa LT, Swift LT for Her, Swift FX, Mirage SoftGel, Quattro FX, Swift FX for Her, Mirage FX, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Quattro Air and Swift FX Nano. Its diagnostic products includes ApneaLink + Oximetry and ApneaLink Plus (U.S.)

Accessories and Other Products

The Company to assist those professionals diagnosing or managing the treatment of patients have data communications and control products, such as the EasyCare, ResLin k, ResControl, ResControl II, TxControl, ResScan and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. These products include humidifiers, such as H5i and H4i, which connect directly with the CPAP, VPAP and AutoSet flow generators to humidify and heat the air delivered to the patient, helping to prevent the drying of nasal passages that can cause discomfort. Other optional accessories include cold passover humidifiers, carry bags and breathing circuits. The Company’s data/patient management products include S9 Embletta Adapter, ResScan v3.14, ResTraxx v17.1., ResTraxx v18.3, ResScan v3.16 and EasyCare 1.0.

The Company competes with Philips BV, DeVilbiss Healthcare., Fisher & Paykel Healthcare Corporation Limited, Apex Medical Corp, BMC Medical Co. Ltd and Weinmann Gerate fur Medizin GmbH + Co. KG.

Advisors’ Opinion:

  • [By Roberto Pedone]

     

    Another earnings short-squeeze prospect is medical equipment player ResMed (RMD), which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect ResMed to report revenue of $400.01 million on earnings of 64 cents per share.

     

    The current short interest as a percentage of the float for ResMed is extremely high at 25.6%. That means that out of the 139.26 million shares in the tradable float, 35.89 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 5%, or by about 1.72 million shares. If the bears get caught pressing their bets into a bullish quarter, then shares of RMD could easily trend sharply higher post-earnings as the shorts rush to cover some of their positions.

     

    From a technical perspective, RMD is currently trending above its 50-day moving average and just below its 200-day moving average, which is neutral trendwise. Shares of RMD have started to flirt with a near-term breakout trade today, since the stock has tested some past overhead resistance at $48.07 a share. That move is starting to push shares of RMD within range of triggering a much bigger breakout trade post-earnings.

     

    If you’re bullish on RMD, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some key overhead resistance levels at $51.22 to $51.32 share with high volume. Look for volume on that move that hits near or above its three-month average action of 1.17 million shares. If that breakout hits post-earnings, then RMD will set up to re-fill some of its previous gap-down-day zone from October of 2013 that started just above $56 a share. If that gap gets filled with strong upside volume flows, then RMD could easily trend north of $60 a share.

     

    I would simply avoid RMD or look for short-biased trades if after earnings

  • [By Damian Illia]

    A Delaware corporation formed in 1994, ResMed Inc. (RMD) is a global leading designer, developer, manufacturer and marketer of medical products for the diagnosis, treatment and management of sleep-disordered breathing (SDB) and other respiratory disorders. For the quarter ended in Dec. 31, 2013 ResMed reported a 2 percent increase (a 1 percent increase in constant currency basis) in revenue over the quarter ended in Dec. 31, 2012. However, these earnings failed to meet analyst estimates; and not without a reason. A relatively poor performance was expected due to continued pressure in the United States, especially as a consequence of the market’s restructuring due to competitive Medicare bidding. This might also be one of the reasons why this stock still remains undervalued.

  • [By Ben Levisohn]

    Resmed (RMD) has plunged 12% to $49.50 in after-hours trading after it reported a profit of 56 cents, below estimates of 58 cents.

    Cliffs Natural Resources (CLF) has gained after it reported a profit of 68 cents, missing forecasts for 71 cents, but beat on revenue.

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at ResMed (NYSE: RMD  ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is ResMed doing by this quick checkup? At first glance, pretty well. Trailing-12-month revenue increased 10.0%, and inventory decreased 9.3%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue increased 9.9%, and inventory shrank 9.3%. Over the sequential quarterly period, the trend looks healthy. Revenue grew 1.9%, and inventory dropped 14.5%.